While some chains are rapidly expanding their scan-based trading programs, others are still taking a wait-and-see approach. After years of tests on scan-based trading, supermarkets continue to ...
FIT outperformed cfDNA in detecting advanced precancerous colorectal lesions, showing higher sensitivity and specificity. Blood-based tests offer easier implementation and potentially higher adherence ...